Explore BIOENSIS 3D Immuno-oncology platform to evaluate your biological samples. Our unique 3D antibody-dependent cellular cytotoxicity (ADCC) and retargeted T cell cytotoxicity platforms enable efficacy evaluation of therapeutic antibodies in 2D/3D cultures.
Key assay features:
• Over 150 target tumor cell lines available for testing
• PBMC's, NK's and T cells available for testing
• Models tested in high-throughput format
• Precision EC50 results
• Flexible testing protocols including single and combination agents
• Available in 2D and 3D cultures
Please contact us to discuss your study needs and an up to date list of available cell lines info@bioensis.com
